Company Expands its Reach to Market its Medical Devices to over 155,000 Physical Therapists Nationwide
CHARLES TOWN, W.Va., Sept. 10 /PRNewswire/ -- ReBuilder Medical Technologies, Inc. , an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced a marketing agreement with Affiliated Services, Inc. of Tampa, Florida. The marketing agreement enables Affiliated Services to market ReBuilder’s products to the entire market of 155,000 physical therapists across the U.S.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
Recently, Affiliated Services conducted the rollout of the Anodyne infrared therapy unit for Neuropathy to over 1,500 physical therapy clinics and has instant access to those clinics. The ReBuilder System(R) compliments the Anodyne product because use of both units would vastly improve a patient’s well being while adding thousands of dollars to a clinic’s bottom line.
“Incidents of diabetes, especially among baby boomers, increase drastically every year. Nerve pain and numbness, will affect 30% to 60% of them. We have the only viable therapy that treats the cause of the disease not just the symptoms and we’re geared up to supply this demand” stated Daena Carter, COO of ReBuilder Medical Technologies, Inc.
The marketing agreement with Affiliated Services is part of ReBuilder Medical Technologies, Inc.'s strategy to reach consumers through their trusted advisors.
We can reach a larger segment of our market through strategic partnerships like this one with Affiliated Services who have direct access to physical therapists,” says Dr. David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. “By entering the offices of therapists, diabetes sufferers will get access to our product directly from their trusted caregivers which will only serve to increase the positive notoriety we have gained over the past five years. Physical Therapists gain by purchasing the device and consumable supplies at wholesale and selling them retail.”
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical’s flagship product is its FDA registered ReBuilder System(R) for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(tm) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the Molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located in Charles Town, WV. He is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System for the early detection of breast cancer and the AcuPen which simultaneously detects and balances acupuncture points.
More information on ReBuilder Medical Technologies, Inc. and its products can be found at: www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comReBuilder Medical Technologies, Inc.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,+1-304-725-2202
Web site: http://www.rebuildermedical.com/
